SCHEMBL20127200

SCHEMBL20127200

CC1(C)OB(c2ccc(C3(c4ccccc4)c4ccccc4-c4ccc5ccccc5c43)cc2)OC1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 13/20 0.43
LPL P06858 12/20 0.43
P4HB P07237 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
OPRK1 P41145 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.31
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
CA9 Q16790 2/20 0.30
CA12 O43570 1/20 0.30
CA3 P07451 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA5A P35218 1/20 0.30
CA7 P43166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28894783 0.88 LIPG (0.43) LIPGLPLP4HBIRAK4
SCHEMBL19822206 0.86 LIPG (0.45) LIPGLPLKDM4EMEN1MAPT
SCHEMBL19151958 0.86 LIPG (0.45) LIPGLPLKDM4EMEN1MAPT
SCHEMBL20127215 0.84 LPL (0.43) LIPGLPLP4HBKDM4EMEN1
SCHEMBL16800692 0.84 LIPG (0.56) LIPGLPLP4HBKDM4EMEN1
SCHEMBL19735704 0.83 LIPG (0.49) LIPGLPLP4HBKDM4EMEN1
SCHEMBL24328635 0.82 LPL (0.40) LIPGLPLKDM4EMEN1LMNA
SCHEMBL17816657 0.82 LIPG (0.54) LIPGLPLP4HBKDM4EMEN1
SCHEMBL20127199 0.81 LIPG (0.44) LIPGLPLP4HBKDM4EMEN1
SCHEMBL15032552 0.81 LPL (0.54) LIPGLPLP4HBKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2020-08-18 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 LIPG 2138/4885LPL 1624/4885P4HB 3179/4885
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 LIPG 2138/4885LPL 1624/4885P4HB 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.